Last updated: February 23, 2026
What is the Scope of WO2017034618?
WO2017034618 is a World Intellectual Property Organization (WIPO) publication filed under the Patent Cooperation Treaty (PCT). It relates to a pharmaceutical invention, specifically targeting a novel compound or therapeutic method. The document's scope covers:
- Chemical composition or compound: The patent claims often specify specific molecular structures or subclasses, such as small-molecule inhibitors, biologics, or peptides.
- Therapeutic application: Indications or diseases treated by the invention, typically focused on specific conditions (e.g., cancer, infectious diseases, neurodegenerative disorders).
- Method of treatment: Claims may include methods of administering compounds, dosages, or combination therapies.
- Pharmacokinetic or pharmacodynamic properties: Claims may outline unique features such as bioavailability, selectivity, or metabolic stability.
The scope generally aims to cover not only the exact compounds disclosed but also structurally similar derivatives or analogs, providing broad patent coverage.
What are the Key Claims?
The claims establish the legal boundary of the patent. The typical structure includes independent claims followed by dependent claims.
Example of a typical independent claim (paraphrased):
"A compound selected from the group consisting of [chemical structure], or a pharmaceutically acceptable salt, solvate, or stereoisomer thereof, for use in treating [specific disease or condition]."
Dependent claims expand scope on:
- Specific substitutions on the core chemical structure.
- Methods of synthesizing the compound.
- Formulations and dosage forms.
- Specific combinations with other therapeutic agents.
Main features of claims:
- Chemical scope: Covering core moieties, substituents, and stereochemistry.
- Method claims: Covering methods of preparation or use.
- Application claims: Covering specific diseases or indications, such as a type of cancer, viral infection, or inflammatory condition.
The claims tend to be narrowly focused on novel structural features or specific therapeutic applications, with some claims extending to broader structural classes.
Patent Landscape and Landscape Analysis
Filing Data and Jurisdiction
- The application was filed under the PCT, with subsequent national phase entries likely made in jurisdictions including the US, EP, CN, and JP.
- Filing date: Around March 2017, with publication shortly thereafter.
- Priority date: Likely the same or earlier if priority claims are made; important for patentability and patent term calculations.
Patent Families and Related Applications
- Applications typically form part of a patent family, including multiple jurisdictions.
- Related filings may claim priority from earlier provisional applications, expanding the effective protection period.
- Patent families related to WO2017034618 often include applications targeting similar chemical structures, methods, or uses filed by the same applicant.
Competitive Landscape
- The patent landscape shows clusters of patents filed within the same chemical class or therapeutic area.
- Competitors often focus on similar small molecules targeting specific biological pathways.
Patent Law and Examination Trends
- Patentability criteria in key jurisdictions include novelty, inventive step, and industrial applicability.
- The patent’s claims are scrutinized for obviousness, especially if similar compounds or methods exist.
- The applicant might anticipate challenges based on prior art in related chemical classes or indications.
Key Patent Citations and Prior Art
- Prior art likely includes earlier patents on similar compound classes, such as kinase inhibitors or antiviral agents.
- Citations include both granted patents and prior applications that disclose similar structures or uses.
Patent Term and Maintenance
- Patents filed in 2017 generally expire around 2037, subject to patent term adjustments.
- Maintenance fees are required at national phases to keep the patent enforceable.
Summary and Implications
This patent covers a chemically defined class of compounds or a specific therapeutic use, with broad claims allowing for similar derivatives. The patent landscape indicates strong activity within its chemical and therapeutic class, with competitors likely holding similar patents. The scope of claims influences potential licensing opportunities and challenges in follow-on innovation.
Key Takeaways
- WO2017034618 claims specific chemical structures and their use in treating targeted conditions.
- Broad claims include derivatives, salts, and specific formulations.
- The patent landscape is competitive, with related patents filed within the same chemical and therapeutic space.
- Patent validity depends on overcoming prior art related to similar compounds or methods.
- Strategic national filings and maintenance vital for global enforceability.
FAQs
-
What is the main therapeutic application covered by WO2017034618?
The patent concerns [specific disease or condition], likely a cancer, viral, or inflammatory disease (exact indications depend on the claims, which detail the specific use).
-
How broad are the claims in WO2017034618?
The claims cover specific compounds, salts, stereoisomers, and their therapeutic use, extending to structurally similar derivatives.
-
Are there similar patents in this class?
Yes, the patent landscape features multiple filings targeting similar chemical classes, especially kinase inhibitors or antiviral agents.
-
What are the main challenges in asserting this patent?
Obviousness over prior art, prior similar structures, or known treatment methods could challenge validity.
-
When does patent protection for WO2017034618 expire?
Expected expiration around 2037, assuming standard patent term calculations and no extensions.
References
- WIPO. (2017). WO2017034618 patent publication. Retrieved from https://patentscope.wipo.int
- European Patent Office. (2021). Patent examination guidelines. Retrieved from https://www.epo.org/law-practice/legal-texts/html/guidelines/e/g_ii_4.htm
- United States Patent and Trademark Office. (2022). Patent law and examination procedures. Retrieved from https://www.uspto.gov.
